Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours

Status:
Terminated

Trial end date:
2012-09-01

Target enrollment:

Participant gender:

This study is being conducted to assess the safety, tolerability and PK of AZD1480 in patients with advanced solid malignancies.

Phase 1

AstraZeneca